Inhibition of bovine leukaemia virus replication by the antisense RNA in cell line CC81.
A model system has been developed for quantitative evaluation of bovine leukaemia virus (BLV) replication in a permanent cell line CC81. Transfection of the BLV DNA into these cells evoked typical signs of retroviral infection: formation of syncytia, manifestation of reverse transcriptase activity and appearance of characteristic budding retroviral particles. To inhibit BLV replication, a recombinant plasmid pAGR with an antisense RNA gene targeted at the R-U5 region (147th-342th nt) of the viral genome has been engineered. Cotransfection of CC81 cells with infectious BLV DNA and pAGR led to effective inhibition of BLV replication by the antisense RNA, evidenced by a drop in the number of syncytia and reverse transcriptase activity. Maximal inhibition of BLV replication (95-97%) was observed at a weight ratio of input viral and plasmid DNAs equal to 1:10.
Borisenko
A
A
Institute of Agricultural Biotechnology, Moscow, Russia.
Miroschnickhenko
O
O
Tikchonenko
T I
TI
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002415:Cats; D002461:Cell Line, Transformed; D003001:Cloning, Molecular; D005818:Genetic Engineering; D001909:Leukemia Virus, Bovine / Q000187:drug effects / Q000502:physiology*; D008958:Models, Molecular; D010957:Plasmids; D016372:RNA, Antisense / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D016372:RNA, Antisense